Related references
Note: Only part of the references are listed.Inhibition of gastric tumor growth by a novel Hsp90 inhibitor
Chunwan Lu et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Synthesis of 19-substituted geldanamycins with altered conformations and their binding to heat shock protein Hsp90
Russell R. A. Kitson et al.
NATURE CHEMISTRY (2013)
Routine Access to Millisecond Time Scale Events with Accelerated Molecular Dynamics
Levi C. T. Pierce et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)
Fluorine- and rhenium-containing geldanamycin derivatives as leads for the development of molecular probes for imaging Hsp90
Frank Wuest et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2012)
ACPYPE - AnteChamber PYthon Parser interfacE
Alan W. Sousa da Silva et al.
BMC RESEARCH NOTES (2012)
HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab
Shanu Modi et al.
CLINICAL CANCER RESEARCH (2011)
Potent Cytotoxic C-11 Modified Geldanamycin Analogues
Zong-Qiang Tian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
The many roles for fluorine in medicinal chemistry
William K. Hagmann
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites
Kyeong Lee et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2008)
A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma
Ellen A. Ronnen et al.
INVESTIGATIONAL NEW DRUGS (2006)
Automatic atom type and bond type perception in molecular mechanical calculations
Junmei Wang et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2006)
Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance
ER Glaze et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors
JL Grem et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bioisosterism: A useful strategy for molecular modification and drug design
LMA Lima et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Synthesis and biological activities of novel 17-aminogeldanamycin derivatives
ZQ Tian et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Oral exposure to benzo[a] pyrene in the mouse:: Detoxication by inducible cytochrome P450 is more important than metabolic activation
S Uno et al.
MOLECULAR PHARMACOLOGY (2004)
Synthesis of novel fluorescent probes for the molecular chaperone Hsp90
L Llauger-Bufi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Improved synthesis and evaluation of 17-substituted aminoalkylgeldanamycin derivatives applicable to drug delivery systems
Y Kasuya et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Share Paper
